Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination.

Saved in:
Bibliographic Details
Title: Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination.
Authors: Abbad A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lerman B; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Ehrenhaus J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Monahan B; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Singh G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Wilson A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Slamanig S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Aracena A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lyttle N; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Nardulli JR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Farrugia K; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Khalil Z; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gonzalez-Reiche AS; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sordillo ME; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., van Bakel H; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Ludwig Boltzmann Institute for Science Communication and Pandemic Preparedness at the Medical University of Vienna, Medical University of Vienna, Vienna, Austria.; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
Source: MBio [mBio] 2026 Jan 14; Vol. 17 (1), pp. e0290125. Date of Electronic Publication: 2025 Nov 25.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2150-7511
DOI:10.1128/mbio.02901-25